Physician profile
David Kloth
NPI 1336137058
$167,474.00
in general payments reported to CMS, 2019-2025
18 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $905 · 2021: $611 · 2022: $922 · 2023: $120K · 2024: $553 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $100K · Debt Forgiveness: $19K · Food and Beverage: $1,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $100,000.00 |
| Debt Forgiveness | $19,143.00 |
| Food and Beverage | $1,932.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $100,000.00 | 2023 | |
| Boston Scientific Corporation | $33,082.43 | 2019-2024 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Medtronic, INC. | $19,196.09 | 2023-2025 | Accurian |
| Stimwave Technologies Incorporated | $13,086.80 | 2019 | |
| Saluda Medical Americas, INC. | $1,006.36 | 2023-2025 | Evoke, Evoke Scs |
| Abbott Laboratories | $455.80 | 2020-2023 | Proclaim |
| Epimed International, INC | $128.01 | 2019 | |
| Depuy Synthes Sales INC. | $122.02 | 2019 | |
| Spr Therapeutics, INC | $111.42 | 2023-2024 | Sprint Pns System |
| Medtronic USA, INC. | $98.68 | 2019 | |
| Nevro Corp. | $88.24 | 2020 | |
| Kaleo, INC. | $21.20 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.09 | 2020 | |
| Collegium Pharmaceutical, INC. | $13.42 | 2022 | |
| Tersera Therapeutics LLC | $12.81 | 2023 | Prialt |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.26 | 2019 | |
| Abbvie INC. | $12.22 | 2022 | |
| Bioventus LLC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kloth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.